Goldman Sachs’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
831,206
-225,693
-21% -$596K ﹤0.01% 3353
2025
Q1
$3.18M Sell
1,056,899
-84,637
-7% -$255K ﹤0.01% 3059
2024
Q4
$2.92M Sell
1,141,536
-147,371
-11% -$377K ﹤0.01% 3248
2024
Q3
$4.79M Buy
1,288,907
+263,932
+26% +$982K ﹤0.01% 2788
2024
Q2
$6.48M Sell
1,024,975
-190,406
-16% -$1.2M ﹤0.01% 2430
2024
Q1
$6.53M Sell
1,215,381
-63,257
-5% -$340K ﹤0.01% 2370
2023
Q4
$6.42M Buy
1,278,638
+850,874
+199% +$4.27M ﹤0.01% 2420
2023
Q3
$723K Buy
427,764
+154,644
+57% +$261K ﹤0.01% 3705
2023
Q2
$759K Sell
273,120
-80,441
-23% -$224K ﹤0.01% 3765
2023
Q1
$643K Sell
353,561
-798,163
-69% -$1.45M ﹤0.01% 3942
2022
Q4
$5.84M Buy
1,151,724
+585,881
+104% +$2.97M ﹤0.01% 2507
2022
Q3
$2.81M Sell
565,843
-4,997
-0.9% -$24.8K ﹤0.01% 3093
2022
Q2
$2.12M Buy
570,840
+162,665
+40% +$605K ﹤0.01% 3399
2022
Q1
$2.29M Buy
408,175
+146,476
+56% +$822K ﹤0.01% 3480
2021
Q4
$1.59M Buy
261,699
+35,952
+16% +$219K ﹤0.01% 3658
2021
Q3
$2.2M Buy
225,747
+29,340
+15% +$286K ﹤0.01% 3412
2021
Q2
$2.8M Buy
196,407
+115,265
+142% +$1.65M ﹤0.01% 3239
2021
Q1
$1.93M Buy
81,142
+24,523
+43% +$582K ﹤0.01% 3406
2020
Q4
$755K Sell
56,619
-1,081
-2% -$14.4K ﹤0.01% 3612
2020
Q3
$400K Buy
+57,700
New +$400K ﹤0.01% 3773
2020
Q2
Sell
-80,447
Closed -$232K 4452
2020
Q1
$232K Buy
+80,447
New +$232K ﹤0.01% 3879
2019
Q3
Sell
-77,032
Closed -$79K 4275
2019
Q2
$79K Buy
+77,032
New +$79K ﹤0.01% 4036
2019
Q1
Sell
-78,821
Closed -$92K 4212
2018
Q4
$92K Buy
78,821
+42,870
+119% +$50K ﹤0.01% 3901
2018
Q3
$133K Sell
35,951
-51,246
-59% -$190K ﹤0.01% 3897
2018
Q2
$267K Buy
87,197
+27,403
+46% +$83.9K ﹤0.01% 3772
2018
Q1
$233K Buy
59,794
+13,729
+30% +$53.5K ﹤0.01% 3788
2017
Q4
$207K Buy
46,065
+2,807
+6% +$12.6K ﹤0.01% 3815
2017
Q3
$237K Sell
43,258
-8,951
-17% -$49K ﹤0.01% 3819
2017
Q2
$396K Sell
52,209
-14,908
-22% -$113K ﹤0.01% 3661
2017
Q1
$238K Buy
67,117
+348
+0.5% +$1.23K ﹤0.01% 3879
2016
Q4
$382K Buy
66,769
+35,811
+116% +$205K ﹤0.01% 3597
2016
Q3
$241K Buy
30,958
+910
+3% +$7.08K ﹤0.01% 3814
2016
Q2
$187K Sell
30,048
-61,761
-67% -$384K ﹤0.01% 3892
2016
Q1
$755K Sell
91,809
-136,786
-60% -$1.12M ﹤0.01% 3001
2015
Q4
$3.96M Buy
+228,595
New +$3.96M ﹤0.01% 2175